Table 3.
The clinicopathological features of NSCLC patients with differential expressions of PD-L1 mRNA
Parameters | Cases | PD-L1 mRNA | P value | |
---|---|---|---|---|
High | Low | |||
Age | 0.062 | |||
≥ 55 | 35 | 16 | 19 | |
< 55 | 15 | 5 | 10 | |
Gender | 0.523 | |||
Male | 25 | 14 | 11 | |
Female | 25 | 7 | 18 | |
TNM stage | 0.031 | |||
I/II | 18 | 12 | 6 | |
III/IV | 32 | 9 | 23 | |
Pathological Type | 0.511 | |||
Suqamous | 21 | 8 | 13 | |
Adenocarcinoma | 12 | 7 | 5 | |
Large Cell Lung cancer | 17 | 6 | 11 | |
Smoking status | 0.345 | |||
Non-smoker | 14 | 6 | 8 | |
Smoker | 16 | 7 | 9 | |
Heavy smoker | 20 | 8 | 12 | |
Lymphatic Metastasis | 0.011 | |||
No | 29 | 7 | 22 | |
Yes | 21 | 14 | 7 |